Genetic testing in steroid-resistant nephrotic syndrome: When and how?

Nephrology Dialysis Transplantation

Volumn 31, Issue 11, 2016, Pages 1802-1813

  Lovric, Svjetlana ^a   Ashraf, Shazia ^a   Tan, Weizhen ^a   Hildebrandt, Friedhelm ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

clinical genetic testing; molecular genetics; monogenic disease; pathogenesis of nephrotic syndrome; steroidresistant nephrotic syndrome (SRNS)

Indexed keywords

UBIDECARENONE; GENETIC MARKER;

CONGENITAL NEPHROTIC SYNDROME; DOMINANT GENE; EDEMA; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HYPOALBUMINEMIA; KIDNEY BIOPSY; MUTATIONAL ANALYSIS; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEINURIA; RECESSIVE GENE; REVIEW; SEQUENCE ANALYSIS; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING; DNA MUTATIONAL ANALYSIS; GENETIC MARKER; GENETICS; MUTATION; NEPHROTIC SYNDROME; PROCEDURES;

DNA MUTATIONAL ANALYSIS; GENETIC MARKERS; GENETIC TESTING; HUMANS; MUTATION; NEPHROTIC SYNDROME;

EID: 84996590429     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv355     Document Type: Review

References (77)

1. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71: 1205-1214
2. Hildebrandt F. Genetic kidney diseases. Lancet 2010; 375: 1287-1295
3. Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 2010; 25: 1621-1632
4. Caridi G, Trivelli A, Sanna-Cherchi S et al. Familial forms of nephrotic syndrome. Pediatr Nephrol 2010; 25: 241-252
5. Smith JM, Stablein DM, Munoz R et al. Contributions of the transplant registry: the 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant 2007; 11: 366-373
6. Benoit G, Machuca E, Heidet L et al. Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes. Ann N Y Acad Sci 2010; 1214: 83-98
7. Ashraf S, Gee HY, Woerner S et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest 2013; 123: 5179-5189
8. Gupta IR, Baldwin C, Auguste D et al. ARHGDIA: a novel gene implicated in nephrotic syndrome. J Med Genet 2013; 50: 330-338
9. Lowik MM, Groenen PJ, Pronk I et al. Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int 2007; 72: 1198-1203
10. Sethi S, Fervenza FC, Zhang Y et al. Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factorHand C3.AmJ Kidney Dis 2012; 60: 316-321
11. Diomedi-Camassei F, Di Giandomenico S, Santorelli FM et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 2007; 18: 2773-2780
12. Heeringa SF, Chernin G, ChakiMet al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 2011; 121: 2013-2024
13. Ebarasi L, Ashraf S, Bierzynska A et al. Defects of CRB2 cause steroid-resistant nephrotic syndrome. Am J Hum Genet 2015; 96: 153-161
14. Ovunc B, Otto EA, Vega-Warner V et al. Exome sequencing reveals cubilin mutation as a single-gene cause of proteinuria. J Am Soc Nephrol 2011; 22: 1815-1820
15. Ozaltin F, Li B, Rauhauser A et al. DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol 2013; 24: 377-384
16. Gee HY, Ashraf S,Wan X et al. Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am J Hum Genet 2014; 94: 884-890
17. Has C, Sparta G, Kiritsi D et al. Integrin alpha3 mutations with kidney, lung, and skin disease. N Engl J Med 2012; 366: 1508-1514
18. Kambham N, Tanji N, Seigle RL et al. Congenital focal segmental glomerulosclerosis associated with beta4 integrin mutation and epidermolysis bullosa. Am J Kidney Dis 2000; 36: 190-196
19. Gee HY, Zhang F, Ashraf S et al. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J Clin Invest 2015; 125: 2375-2384
20. Zenker M, Aigner T, Wendler O et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004; 13: 2625-2632
21. Yasukawa T, Suzuki T, Ueda T et al. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J Biol Chem 2000; 275: 4251-4257
22. Mele C, Iatropoulos P, Donadelli R et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis.NEngl JMed 2011; 365: 295-306
23. Kestila M, Lenkkeri U, Mannikko M et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1: 575-582
24. Boute N, Gribouval O, Roselli S et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24: 349-354
25. Miyake N, Tsukaguchi H, Koshimizu E et al. Biallelic mutations in nuclear pore complex subunit NUP107 cause early-childhood-onset steroid-resistant nephrotic syndrome. Am J Hum Genet. 2015; 97: 555-566
26. Lopez LC, SchuelkeM,QuinziiCMet al. Leigh syndromewith nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 2006; 79: 1125-1129
27. Hinkes B,Wiggins RC, Gbadegesin R et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006; 38: 1397-1405
28. Ozaltin F, Ibsirlioglu T, Taskiran EZ et al. Disruption of PTPRO causes childhood-onset nephrotic syndrome. Am J Hum Genet 2011; 89: 139-147
29. Berkovic SF, Dibbens LM, Oshlack A et al. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet 2008; 82: 673-684
30. Boerkoel CF, Takashima H, John J et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 2002; 30: 215-220
31. Colin E, Huynh Cong E, Mollet G et al. Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome. AmJ Hum Genet 2014; 95: 637-648
32. Vodopiutz J, Seidl R, Prayer D et al. WDR73 mutations cause infantile neurodegeneration and variable glomerular kidney disease. Hum Mutat 2015; 36: 1021-1028
33. Jinks RN, Puffenberger EG, Baple E et al. Recessive nephrocerebellar syndrome on the Galloway-Mowat syndrome spectrum is caused by homozygous protein-truncating mutations of WDR73. Brain : a journal of neurology 2015; 138: 2173-2190
34. Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24: 251-256
35. Gbadegesin RA, Hall G, Adeyemo A et al. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS. J Am Soc Nephrol 2014; 25: 1991-2002
36. Akilesh S, Suleiman H, Yu H et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J Clin Invest 2011; 121: 4127-4137
37. Brown EJ, Schlondorff JS, Becker DJ et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet 2010; 42: 72-76
38. Vollrath D, Jaramillo-Babb VL, Clough MV et al. Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome. Hum Mol Genet 1998; 7: 1091-1098
39. McIntosh I, Dreyer SD, CloughMVet al. Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet 1998; 63: 1651-1658
40. Heath KE, Campos-Barros A, Toren A et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001; 69: 1033-1045
41. WinnMP, Conlon PJ, Lynn KL et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308: 1801-1804
42. Jeanpierre C, Denamur E, Henry I et al. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 1998; 62: 824-833
43. Zenker M, Machuca E, Antignac C. Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier. J Mol Med 2009; 87: 849-857
44. Somlo S, Mundel P. Getting a foothold in nephrotic syndrome. Nat Genet 2000; 24: 333-335
45. Kim YH, Goyal M, Kurnit D et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60: 957-968
46. Wharram BL, Goyal M, Wiggins JE et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16: 2941-2952
47. Hinkes BG, Mucha B, Vlangos CN et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 2007; 119: e907-e919
48. Lovric S, Fang H, Vega-Warner V et al. Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2014; 9: 1109-1116
49. Sadowski CE, Lovric S,Ashraf S et al. A single-gene cause in 29.5%of cases of steroid-resistant nephrotic syndrome. JAmSocNephrol 2014; 26: 1279-1289
50. Halbritter J, BaumM,HynesAMet al. Fourteenmonogenic genes account for 15%of nephrolithiasis/nephrocalcinosis. JAmSocNephrol 2015; 26: 543-551
51. Halbritter J, Diaz K, Chaki M et al. High-throughput mutation analysis in patients with a nephronophthisis-associated ciliopathy applying multiplexed barcoded array-based PCR amplification and next-generation sequencing. J Med Genet 2012; 49: 756-767
52. Giglio S, Provenzano A, Mazzinghi B et al. Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol 2015; 26: 230-236
53. Trautmann A, Bodria M, Ozaltin F et al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: The Podonet Registry Cohort. Clin J Am Soc Nephrol 2015; 10: 592-600
54. Lipska BS, Iatropoulos P, Maranta R et al. Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int 2013; 84: 206-213
55. Weber S, Gribouval O, Esquivel EL et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low posttransplant recurrence. Kidney Int 2004; 66: 571-579
56. Ruf RG, Lichtenberger A, Karle SM et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004; 15: 722-732
57. Wan X, Chen Z, Choi WI et al. Loss of epithelial membrane protein 2 aggravates podocyte injury via upregulation of caveolin-1. J Am Soc Nephrol 2015; 27: doi: 10.1681/ASN.2014121197
58. Hildebrandt F, Heeringa SF. Specific podocin mutations determine age of onset of nephrotic syndrome all the way into adult life. Kidney Int 2009; 75: 669-671
59. Hinkes B, Vlangos C, Heeringa S et al. Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2008; 19: 365-371
60. Tory K, Menyhard DK, Woerner S et al. Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome. Nat Genet 2014; 46: 299-304
61. Chernin G, Vega-Warner V, Schoeb DS et al. Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations. Clin J Am Soc Nephrol 2010; 5: 1655-1662
62. Hasselbacher K,Wiggins RC, Matejas Vet al. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int 2006; 70: 1008-1012
63. Boyer O, Nevo F, Plaisier E et al. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy. N Engl J Med 2011; 365: 2377-2388
64. Boyer O,Woerner S, Yang F et al. LMX1B mutations cause hereditary FSGS without extrarenal involvement. J Am Soc Nephrol 2013; 24: 1216-1222
65. Montini G,Malaventura C, Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 2008; 358: 2849-2850
66. Gee HY, Saisawat P, Ashraf S et al. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest 2013; 123: 3243-3253
67. Schlondorff J,Del Camino D, Carrasquillo Ret al. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFATdependent transcription. Am J Physiol Cell Physiol 2009; 296: C558-C569
68. Halbritter J, Porath JD, Diaz KA et al. Identification of 99 novel mutations in a worldwide cohort of 1,056 patients with a nephronophthisis-related ciliopathy. Hum Genet 2013; 132: 865-884
69. Teer JK, Mullikin JC. Exome sequencing: the sweet spot before whole genomes. Hum Mol Genet 2010; 19: R145-R151
70. Ng SB, Turner EH, Robertson PD et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461: 272-276
71. Lifton RP. Individual genomes on the horizon. N Engl J Med 2010; 362: 1235-1236
72. Otto EA, Hurd TW, Airik R et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat Genet 2010; 42: 840-850
73. Yang Y, Muzny DM, Reid JG et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013; 369: 1502-1511
74. Hildebrandt F, Heeringa SF, Ruschendorf F et al. A systematic approach to mapping recessive disease genes in individuals from outbred populations. PLoS Genet 2009; 5: e1000353
75. Lee H, Deignan JL, Dorrani N et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 2014; 312: 1880-1887
76. MacArthur DG, Manolio TA, Dimmock DP et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014; 508: 469-476
77. MacArthur DG, Balasubramanian S, Frankish A et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012; 335: 823-828